Literature DB >> 1678809

Diagnosis of cysticercosis in endemic regions. The Cysticercosis Working Group in Peru.

H H Garcia1, M Martinez, R Gilman, G Herrera, V C Tsang, J B Pilcher, F Diaz, M Verastegui, C Gallo, M Porras.   

Abstract

Taenia solium cysticercosis is a frequent cause of neurological disease in developing countries. Specific diagnosis of cysticercosis is difficult. We obtained serum and/or CSF samples from 204 consecutive patients admitted to a neurological ward in Lima, Peru, and looked for antibodies specific for T solium with the enzyme-linked immunoelectrotransfer blot (EITB) assay. 21 (12%) of 173 serum samples from these patients were EITB-positive. In contrast, only 2 (1.5%) of 135 patients attending a public endoscopy clinic and 1 (1%) of 88 patients attending a private endoscopy clinic were seropositive. 1 (1%) of 98 pregnant women living in a Lima shanty town was EITB-positive. 15 (58%) of 26 neurology patients diagnosed clinically as having cysticercosis were seronegative. Routine screening by EITB of all patients with neurological symptoms from areas of endemic cysticercosis would avoid misdiagnosis of this common and treatable disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1678809      PMCID: PMC2913119     

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  12 in total

1.  [Cysticercosis of the central nervous system].

Authors:  J Nava Segura
Journal:  Salud Publica Mex       Date:  1983 May-Jun

2.  [Clinical aspects of neurocysticercosis: analysis of 500 cases].

Authors:  O M Takayanagui; E Jardim
Journal:  Arq Neuropsiquiatr       Date:  1983-03       Impact factor: 1.420

Review 3.  Cerebral cysticercosis in San Diego. A report of 23 cases and a review of the literature.

Authors:  L Loo; A Braude
Journal:  Medicine (Baltimore)       Date:  1982-11       Impact factor: 1.889

Review 4.  Recent advances in the diagnosis and treatment of cerebral cysticercosis.

Authors:  T E Nash; F A Neva
Journal:  N Engl J Med       Date:  1984-12-06       Impact factor: 91.245

5.  Enzyme-linked immunosorbent assay for the diagnosis of cerebral cysticercosis.

Authors:  I N Mohammad; D C Heiner; B L Miller; M A Goldberg; I G Kagan
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

6.  Cysticercosis cerebri. Review of 127 cases.

Authors:  G F McCormick; C S Zee; J Heiden
Journal:  Arch Neurol       Date:  1982-09

7.  Differential diagnosis between ventriculitis and fourth ventricle cyst in neurocysticercosis.

Authors:  A Salazar; J Sotelo; H Martinez; F Escobedo
Journal:  J Neurosurg       Date:  1983-10       Impact factor: 5.115

8.  Neurocysticercosis in Mexico.

Authors:  A Flisser
Journal:  Parasitol Today       Date:  1988-05

9.  Cysticerciasis and epilepsy: a clinical and serological study.

Authors:  J S Chopra; U Kaur; R C Mahajan
Journal:  Trans R Soc Trop Med Hyg       Date:  1981       Impact factor: 2.184

10.  Cysticercotic encephalitis: a severe form in young females.

Authors:  R Rangel; B Torres; O Del Bruto; J Sotelo
Journal:  Am J Trop Med Hyg       Date:  1987-03       Impact factor: 2.345

View more
  20 in total

Review 1.  A comprehensive review of imaging findings in human cysticercosis.

Authors:  Bargavee Venkat; Neeti Aggarwal; Sushma Makhaik; Ramgopal Sood
Journal:  Jpn J Radiol       Date:  2016-02-23       Impact factor: 2.374

2.  Epidemiology of taeniasis and cysticercosis in a Peruvian village. The Cysticercosis Working Group in Peru.

Authors:  F Diaz; H H Garcia; R H Gilman; A E Gonzales; M Castro; V C Tsang; J B Pilcher; L E Vasquez; M Lescano; C Carcamo
Journal:  Am J Epidemiol       Date:  1992-04-15       Impact factor: 4.897

3.  Immunotherapy for porcine cysticercosis: implications for prevention of human disease. Cysticercosis Working Group in Peru.

Authors:  C A Evans; A E Gonzalez; R H Gilman; M Verastegui; H H Garcia; A Chavera; J B Pilcher; V C Tsang
Journal:  Am J Trop Med Hyg       Date:  1997-01       Impact factor: 2.345

Review 4.  Proposed diagnostic criteria for neurocysticercosis.

Authors:  O H Del Brutto; V Rajshekhar; A C White; V C Tsang; T E Nash; O M Takayanagui; P M Schantz; C A Evans; A Flisser; D Correa; D Botero; J C Allan; E Sarti; A E Gonzalez; R H Gilman; H H García
Journal:  Neurology       Date:  2001-07-24       Impact factor: 9.910

5.  Magnitude of the disease burden from neurocysticercosis in a developing country.

Authors:  C Bern; H H Garcia; C Evans; A E Gonzalez; M Verastegui; V C Tsang; R H Gilman
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

6.  The marketing of cysticercotic pigs in the Sierra of Peru. The Cysticercosis Working Group in Peru.

Authors: 
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

Review 7.  Taenia solium cysticercosis.

Authors:  Héctor H García; Armando E Gonzalez; Carlton A W Evans; Robert H Gilman
Journal:  Lancet       Date:  2003-08-16       Impact factor: 79.321

8.  Accuracy of serological testing for the diagnosis of prevalent neurocysticercosis in outpatients with epilepsy, Eastern Cape Province, South Africa.

Authors:  Humberto Foyaca-Sibat; Linda D Cowan; Hélène Carabin; Irene Targonska; Mushtaq A Anwary; Gilberto Serrano-Ocaña; Rosina C Krecek; A Lee Willingham
Journal:  PLoS Negl Trop Dis       Date:  2009-12-08

Review 9.  Management of neurocysticercosis.

Authors:  Terrence Riley; A C White
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 10.  Epidemiology and management of cysticercosis and Taenia solium taeniasis in Europe, systematic review 1990-2011.

Authors:  Lorenzo Zammarchi; Marianne Strohmeyer; Filippo Bartalesi; Elisa Bruno; José Muñoz; Dora Buonfrate; Alessandra Nicoletti; Héctor Hugo García; Edoardo Pozio; Alessandro Bartoloni
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.